Merck & Co., Inc. (MRK): How Do the Books Stack Up?

It is interesting to note that Merck & Co., Inc. (NYSE:MRK) is active and made a solid movement in the last trading day. Now trading with a market value of 157.26B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Merck & Co., Inc. (NYSE:MRK) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For MRK, the company currently has 7.9 billion of cash on the books, which is offset by 5.16 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 91.68 billion in total assets, balanced by 53.18 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Merck & Co., Inc. (MRK) saw -1.61 billion in free cash flow last quarter, representing a quarterly net change in cash of 115 million. Perhaps most importantly where cash movements are concerned, the company saw about -1.17 billion in net operating cash flow.

Merck & Co., Inc. (NYSE:MRK) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 10.31 billion in total revenues. That represents a quarterly year/year change in revenues of -0.02 in sequential terms, the MRK saw sales decline by 0.04.

But what about the bottom line? After all, that’s what really matters in the end. Merck & Co., Inc. (MRK) is intriguing when broken down to its core data. The cost of selling goods last quarter was 3.25 billion, yielding a gross basic income of 7.06 billion. For shareholders, given the total diluted outstanding shares of 2.73 billion, this means overall earnings per share of -0.02. Note, this compares with a consensus analyst forecast of 0.94 in earnings per share for its next fiscal quarterly report.

Is Merck & Co., Inc. (NYSE:MRK) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 4.08 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 14.15. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Merck & Co., Inc..

Previous ArticleNext Article

Related Post

Philip Morris International Inc. (PM) Makes An Int... Philip Morris International Inc. (NYSE:PM) is an interesting stock at present. Now trading with a market value of 167.91B, the company has a mix of ca...
The Fundamental Case for and Against General Mills... General Mills, Inc. (NYSE:GIS) is an interesting stock at present. Now trading with a market value of 34.35B, the company has a mix of catalysts and o...
Fifth Third Bancorp (FITB) Makes An Interesting Ca... It is interesting to note that Fifth Third Bancorp (NASDAQ:FITB) is active and made a solid movement in the last trading day. Now trading with a marke...
The Long Case For Adobe Systems Incorporated (ADBE... Adobe Systems Incorporated (NASDAQ:ADBE) is one the of the active stocks and its unusual movement is rasing eyebrows among traders. Now trading with a...
Drilling Down Into the Books for BHP Billiton Limi... BHP Billiton Limited (NYSE:BHP) is in the highlights and many would want to know whether now might be a good time for it to present much upside. Now t...